Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Morphosys AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Bimagrumab (noch?) nicht erfolgreich – F&E-Arbeit mit 104 Projekten auf Rekordniveau

Der therapeutischen Antikörper Bimagrumab von Partner Novartis erreichte in einer Ph 2b/3-Studie in sIBM nicht den primären P...

17 May 2016 EQUI.TS 4 $10.00

MORPHOSYS - PROPRIETARY DEVELOPMENT FRONT AND CENTRE

MorphoSys is a biotechnology company developing antibody-based therapeutics for an array of indications. It is transitioning ...

17 May 2016 Edison Investment Research 12 $10.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) is a pharmaceutical company that develops mon...

13 May 2016 GlobalData 76 $300.00

Will MorphoSys AG Deliver Long-Term Returns?

13 May 2016 Sadif Analytics Prime 12 $25.00

Wright Investors Service Comprehensive Report for MorphoSys AG

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

09 May 2016 Wright Reports 56 $75.00

Morphosys (MOR)

MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully a...

05 May 2016 Acquisdata 11 $15.00

MORG.DE - Event Transcript of Morphosys AG conference call, May 03, 2016 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, May 03, 2016 / 8:00AM ET Boston, May 3, 2016 (Thomson StreetEvents)...

03 May 2016 Thomson Reuters StreetEvents 9 $75.00

MorphoSys AG: Upgraded to Good

22 Mar 2016 Sadif Analytics Prime 3 $10.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) develops monoclonal antibodies for therapeuti...

17 Mar 2016 GlobalData 79 $300.00